-
Protiagregacijska zdravila v sekundarni preventivi ishemičnega možganskožilnega dogodka : slovenska priporočila = Antiplatelet drugs in secondary prevention of cerebral ischemic event : slovenian recommendationsŽvan, BojanaStroke risk is heightened among patients who have had a primary stroke or transient ischaemic attack. Because stroke recurrence can occur shortly after the primary event, European, American, as well ... as Sloevnian guidelines recommend initiating antiplatelet therapy as soon as possible. Aspirin, with or without extended-release dipyridamole, and clopidogrel are options for suchpatients. Low-dose aspirin (100 mg/day) has the same efficacy as higher doses but with less gastrointestinal bleeding. Clopidogrel remains an option for prevention of secondary events and may benefit patients with high risk of symptomatic atherothrombosis, but its combined use with aspirin can harm patients with unstable angina or non q wave myocardial infarction or patients with corronary or carotid angioplasty with stenting. Trials assessing aspirin plus dipyridamole have shown that the combination is more effective than aspirin monotherapy in preventing recurrent stroke. In choosing pharmacological therapy, the physician must consider the individual patient's risk factors and tolerance, as well as. Conclusion: Antiplatelet therapy is effective in secondary stroke prevention. Low dose aspirin can be used first-line, but aspirin plus extended-release dipyridamole improves efficacy. Clopidogrel is another option in secondary stroke prevention, especially for aspirin-intolerant patients, and its combined use with aspirin has only marginally better efficacy and increased bleeding risk, therefore the combination is not recommended in secondary stroke prevention.Vir: Slovenska kardiologija : znanstveno strokovna revija za področje srčno-žilne medicine. - ISSN 1581-8543 (Letn. 4, št. 2, 2007, str. 136-139)Vrsta gradiva - članek, sestavni delLeto - 2007Jezik - slovenskiCOBISS.SI-ID - 23497433
Avtor
Žvan, Bojana
Teme
Cerebral Ischemia |
Cerebral Infarction |
Prevention And Control |
Platelet Aggregation Inhibitors |
Practice Guidelines |
Možganski infarkt |
Trombociti, zlepljenje, inhibitorji |
Praktična navodila |
kardiovaskularne bolezni |
možganska kap |
preventiva |
antiagregacijsko zdravljenje |
smernice
vir: Slovenska kardiologija : znanstveno strokovna revija za področje srčno-žilne medicine. - ISSN 1581-8543 (Letn. 4, št. 2, 2007, str. 136-139)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Žvan, Bojana | 05352 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi